Your current location:HOME >opinions >Chinese inhibitor drug candidate becomes first to enter phase 正文
TIME:2024-04-30 04:02:01 Source: Internet compilationEdit:opinions
Chinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chines
Chinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chinese regulatory authorities for the registration phase-3 clinical trial of a combination therapy using its SHP2 inhibitor drug candidate JAB-3312.
SHP2 inhibitors are expected worldwide to have a substantial clinical effect in cancer and immunity disease treatment, and the approval made JAB-3312 the first SHP2 inhibitor to enter the phase-3 clinical study globally.
The approved clinical study in China is designed to evaluate the efficacy and safety of JAB-3312 in combination with the company's other investigational drug candidate KRAS G12C inhibitor glecirasib, for treating first-line non-small cell lung cancer patients with KRAS G12C mutations.
The control arm is the current standard treatment for first-line non-small cell lung cancer, which is the combination therapy of PD-1 antibody and chemotherapy.
Israeli airstrike kills 14 in Gaza's refugee camp2024-04-30 04:01
Nursery worker accused of killing a nine2024-04-30 03:57
Man arrested after 3 shot to death in central Indiana apartment complex2024-04-30 03:34
Myanmar's jailed former leader Suu Kyi moved from prison to house arrest2024-04-30 03:34
President Xi on global, regional security2024-04-30 03:31
Nigel Farage teases 'very big decision' on returning to frontline politics 'in the next few weeks'2024-04-30 03:21
Maui Fire Department report details how it was no match for unprecedented blazes2024-04-30 03:03
Should I cancel my holiday to Dubai? As UAE is lashed by year2024-04-30 02:43
Recently reinstated receiver Quintez Cephus signs a one2024-04-30 02:42
Tesla asks shareholders to reinstate Elon Musk's $55 billion pay package2024-04-30 01:54
'Flying Apsaras' takes flight in Beijing, set for nationwide tour2024-04-30 03:57
Inflation tumbles to 3.2%2024-04-30 03:43
Supreme Court makes it easier to sue for job discrimination over forced transfers2024-04-30 03:19
Milan's famous La Scala names new director of the opera house after months of controversy2024-04-30 03:17
Algeria hosts 23rd 'Chinese Bridge' language competition for university students2024-04-30 03:13
Olympic champion Suni Lee back in form after debilitating kidney ailment2024-04-30 03:11
Inflation tumbles to 3.2%2024-04-30 03:02
The OTHER glamorous aide supporting Trump at his trial: Meet his golf partner Natalie Harp2024-04-30 02:11
Israeli airstrike kills 14 in Gaza's refugee camp2024-04-30 02:09
House prices fell 0.2% in last year, official figures report2024-04-30 01:37